{
    "nctId": "NCT06560385",
    "briefTitle": "Alleviation of Alopecia in Breast Cancer Patient Using Synbiotics Formula",
    "officialTitle": "A Pilot, Double-blind, Randomised, Placebo-controlled Trial on the Efficacy of a Synbiotic Formula (BLHK03) in Alleviating Chemotherapy-induced Alopecia (CIA) in Breast Cancer Patients",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Hair Loss",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "The proportion of subjects with a score of \u2264 2 on the Dean scale (corresponding to hair loss \u2264 50%) 2 months after the final dose of chemotherapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Females aged between 18 and 60 years who are newly diagnosed with stage I, II or III breast cancer\n* Planned chemotherapy including an anthracycline or taxane to be completed within 6 months\n* Mentally capable to participate in the study and provide informed consent\n\nExclusion Criteria:\n\n* Pre-existing female-pattern baldness resembling picture I-3 or higher on the Savin scale at baseline\n* History of hair transplantation, psoriasis or severe scalp infection\n* Undergoing or plan to receive scalp cooling\n* Plan for immunotherapy\n* Known pregnancy or lactating\n* Severe cardiac, hepatic, renal, pulmonary and haematic lesions or other life-threatening conditions\n* Use of antibiotics, probiotics or prebiotics one month prior to enrolment\n* No other alternative or complementary treatment for the cancer condition that may affect the gut microbiome analysis\n* History of allergy to probiotics or lactose\n* History of chemotherapy for other conditions",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}